Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: A 35-year survey

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 2, 2010, Pages 658-665

  Ly, Long V ^a   Odish, Omar F F ^a   de Wolff Rouendaal, Didi ^a   Missotten, Guy S O A ^a   Luyten, Gregorius P M ^a   Jager, Martine J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER REGISTRY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; ENUCLEATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL; UVEA MELANOMA; BRACHYTHERAPY; HYPERTHERMIC THERAPY; MEGAVOLTAGE RADIOTHERAPY; MELANOMA; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SURVIVAL RATE; TUMOR EMBOLISM; UVEA TUMOR; VASCULARIZATION;

BRACHYTHERAPY; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MELANOMA; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 77449119955     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3824     Document Type: Article

References (46)

1. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110:956-961.
2. Virgili G. Incidence of uveal melanoma in Europe. Ophthalmology. 2008;114(12):2309-2315.
3. Kivela T, Eskelin S, Kujala E. Metastatic uveal melanoma. Int Ophthalmol Clin. 2006;46:133-149.
4. Singh AD, Borden EC. Metastatic uveal melanoma. Ophthalmol Clin North Am. 2005;18:143-150.
5. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005;438:967-974.
6. Folkman J. How is blood-vessel growth regulated in normal and neoplastic tissue. Proc Assoc Cancer Res. 1985;26:384-385.
7. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175-203.
8. Boyd SR, Tan DS, de Souza L et al. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth. Br J Ophthalmol. 2002;86:440-447.
9. Demou ZN, Hendrix MJ. Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma. J Cell Biochem. 2008;105:562-573.
10. Shields CL, Shields JA, De Potter P. Patterns of indocyanine green videoangiography of choroidal tumors. Br J Ophthalmol. 1995;79: 237-245.
11. Singh AD, Rundle PA, Rennie I. Retinal vascular tumors. Ophthalmol Clin North Am. 2005;18:167-176.
12. Foss AJE, Alexander RA, Jefferies LW, et al. Microvessel count predicts survival in uveal melanoma. Cancer Res. 1996;56:2900-2903.
13. Makitie T, Summanen P, Tarkkanen A, Kivela T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 1999;40:2471-2480.
14. Toivonen P, Makitie T, Kujala E, Kivela T. Microcirculation and tumor-infiltrating macrophages choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci. 2004;45:1-6.
15. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, et al. The prognostic value of tumor blood-vessel morphology in primary uveal melanoma. Ophthalmology. 1993;100:1389-1398.
16. Clarijs R, van Dijk M, Ruiter DJ, de Waal RMW. Functional and morphologic analysis of the fluid-conducting meshwork in xenografted cutaneous and primary uveal melanoma. Invest Ophthalmol Vis Sci. 2005;46:3013-3020.
17. Overkleeft ENM, Zuidervaart W, Hurks HMH, et al. Prognostic value of the disodium phosphate P-32 uptake test in uveal melanoma: a long-term study. Arch Ophthalmol. 2003;121:1398-1403.
18. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115:1778-1785.
19. The Collaborative Ocular Melanoma Study Group. Mortality in patients with small choroidal melanoma. COMS report no. 4. Arch Ophthalmol. 1997;115:886-893.
20. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6. Am J Ophthalmol. 1998;125:745-766.
21. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002:193-200.
22. Sobin LH, Witekind C. UICC TNM Classification of Malignant Tumors. 6th ed. New York: Wiley-Liss; 2002:218-222.
23. Callejo SA, Antecka E, Blanco PL, Edelstein C, Burnier MN Jr. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma: a prospective longitudinal study. Eye. 2007;21:752-759.
24. Gabor S, Renner H, Popper H, et al. Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 nonsmall-cell lung cancer. Eur J Cardiothorac Surg. 2004;25:439-442.
25. Macchiarini P, Fontanini G, Hardin MJ, et al. Blood-vessel invasion by tumor-cells predicts recurrence in completely resected T1-N0-M0 non-small-cell lung-cancer. J Thorac Cardiovasc Surg. 1993;106:80-89.
26. Kenneally CZ, Farber MG, Smith ME, Devineni R. In vitro melanoma cell growth after preenucleation radiation therapy. Arch Ophthalmol. 1988;106:223-224.
27. Kivela T, Toivonen P. Analysis of melanoma cell type in uveal melanoma following treatment failure. Am J Ophthalmol. 2005; 140:768-769.
28. Raoof N, Rennie IG, Salvi SM, et al. What is the significance of vortex vein invasion in uveal melanoma? Eye. 2009 Aug;23(8): 1661-7.
29. Folberg R, Pe'er J, Gruman LM, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992;23:1298-1305.
30. Vaupel P, Gabbert H. Evidence for and against a tumor typespecific vascularity. Strahlenther Onkol. 1986;162:633-638.
31. Schuster R, Bechrakis NE, Stroux A, et al. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Clin Cancer Res. 2007;13:1171-1178.
32. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983;101:1894-1899.
33. Affeldt JC, Minckler DS, Azen SP, Yeh L. Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol. 1980;98: 1975-1979.
34. Chisholm JF Jr. A long term follow-up on malignant melanomas of the choroid based on the Terry and Johns series. Am J Ophthalmol. 1953;36:61-75.
35. Kidd MN, Lyness RW, Patterson CC, Johnston PB, Archer DB. Prognostic factors in malignant melanoma of the choroid: a retrospective survey of cases occurring in Northern Ireland between 1965 and 1980. Trans Ophthalmol Soc U K. 1986;105: 114-121.
36. Shammas HF, Blodi FC. Orbital extension of choroidal and ciliary body melanomas. Arch Ophthalmol. 1977;95:2002-2005.
37. Apte RS, Richter J, Herndon J, Ferguson TA. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PloS Med. 2006;3:1371-1381.
38. Dace DS, Apte RS. Effect of senescence on macrophage polarization and angiogenesis. Rejuvenation Res. 2008;11:177-185.
39. Espinosa-Heidmann DG, Suner IJ, Hernandez EP, et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44: 3586-3592.
40. Makitie T, Summanen P, Tarkkanen A, Kivela T. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42:1414-1421.
41. Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003; 44:4651-4659.
42. Seregard S, Kock E. Prognostic indicators following enucleation for posterior uveal melanoma: a multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand. 1995;73:340-344.
43. Scholes AG, Damato BE, Nunn J, et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 2003;44:1008-1011.
44. Sisley K, Rennie IG, Parsons MA, et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer. 1997;19:22-28.
45. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64:7205-7209.
46. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007; 114:1925-1931.